Fred Alger Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $51.5M | Sell |
|
|||||
|
2025
Q1 | $46M | Buy |
|
|||||
|
2024
Q4 | $49.8M | Sell |
|
|||||
|
2024
Q3 | $49M | Buy |
|
|||||
|
2024
Q2 | $43.9M | Buy |
|
|||||
|
2024
Q1 | $41.7M | Sell |
|
|||||
|
2023
Q4 | $99.5M | Buy |
|
|||||
|
2023
Q3 | $64.8M | Buy |
|
|||||
|
2023
Q2 | $53.7M | Buy |
|
|||||
|
2023
Q1 | $32.5M | Buy |
|
|||||
|
2022
Q4 | $23.3M | Sell |
|
|||||
|
2022
Q3 | $25.1M | Sell |
|
|||||
|
2022
Q2 | $22.9M | Sell |
|
|||||
|
2022
Q1 | $41.6M | Sell |
|
|||||
|
2021
Q4 | $42.9M | Sell |
|
|||||
|
2021
Q3 | $36.1M | Sell |
|
|||||
|
2021
Q2 | $68.4M | Buy |
|
|||||
|
2021
Q1 | $71.9M | Buy |
|
|||||
|
2020
Q4 | $128M | Buy |
|
|||||
|
2020
Q3 | $85.7M | Buy |
|
|||||
|
2020
Q2 | $58.8M | Buy |
|
|||||
|
2020
Q1 | $47.6M | Buy |
|
|||||
|
2019
Q4 | $46.4M | Buy |
|
|||||
|
2019
Q3 | $36.3M | Buy |
|
|||||
|
2019
Q2 | $21.2M | Sell |
|
|||||
|
2019
Q1 | $29.5M | Buy |
|
|||||
|
2018
Q4 | $17.2M | Sell |
|
|||||
|
2018
Q3 | $23.1M | Buy |
|
|||||
|
2018
Q2 | $14M | Sell |
|
|||||
|
2018
Q1 | $30.7M | Sell |
|
|||||
|
2017
Q4 | $65.2M | Buy |
|
|||||
|
2017
Q3 | $75.4M | Sell |
|
|||||
|
2017
Q2 | $63.6M | Buy |
|
|||||
|
2017
Q1 | $75M | Buy |
|
|||||
|
2016
Q4 | $56.8M | Sell |
|
|||||
|
2016
Q3 | $69.3M | Sell |
|
|||||
|
2016
Q2 | $77.4M | Buy |
|
|||||
|
2016
Q1 | $45.3M | Buy |
|
|||||
|
2015
Q4 | $13.8M | Sell |
|
|||||
|
2015
Q3 | $29M | Buy |
|
|||||
|
2015
Q2 | $1.46M | Sell |
|
|||||
|
2015
Q1 | $2.03M | Sell |
|
|||||
|
2014
Q4 | $14.3M | Sell |
|
|||||
|
2014
Q3 | $11.5M | Sell |
|
|||||
|
2014
Q2 | $11.8M | Sell |
|
|||||
|
2014
Q1 | $15.8M | Sell |
|
|||||
|
2013
Q4 | $25.5M | Buy |
|
|||||
|
2013
Q3 | $17.6M | Buy |
|
|||||
|
2013
Q2 | $10.1M | Buy |
|